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Assessment: The Road Less TraveledWe read with great interest the recent paper by
Friedman et al. (1). The authors have endeavored to
highlight the importance of early recognition of risk
factors for cardiovascular and cerebrovascular dis-
ease and early management of these risk factors.
However, we would like to highlight a factor worth
considering.
Risk factors are no doubt important in the devel-
opment of subclinical disease; however, we cannot
treat every patient with risk factors, nor can we
perform imaging on everyone with risk factors. This is
just not practical.
However, there is growing evidence (2,3) that
there is a strong correlation between subclinical car-
diac dysfunction and subclinical brain infarcts, for
example, as detected by Russo et al. (4) in the land-
mark CABL (Cardiovascular Abnormalities and Brain
Lesions) trial through speckle tracking echocardiog-
raphy. Therefore, imaging of the heart would be
much more cost-effective in detecting subtle and
pre-clinical changes. Nevertheless, it is an excellent
systematic review that elucidates the importance of
being pre-emptive in the management of any disease
entity, hence reminding us, “get it before it metabo-
lizes you.”Aitzaz Bin Sultan Rai, MD, MSc (oxon)*
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Assessment: The Road Less TraveledWe thank Dr. Rai and colleagues for their interest in
our paper (1). We agree with them on the impor-
tance of these risk factors in the development of
subclinical disease. These risk factors need to be
addressed in accordance with the American Heart
Association/American College of Cardiology guide-
lines to reduce cardiovascular risk (2), and should be
applicable to adults both with and without existing
cardiovascular disease. In our review, we have
gathered evidence from the published studies that
the subjects without symptomatic cardiovascular,
cerebrovascular, or peripheral vascular disease, but
harboring the same risk factors for development of
cardiovascular disease, also experience structural
and functional brain imaging changes with cognitive
consequences. Given that a greater number of per-
sons in our aging population are projected to
develop mild forms of vascular cognitive impair-
ment and cardiovascular disease, it is important,
through continued imaging investigations, to gain a
better understanding of the mechanisms underlying
their mutual development. Such research endeavors
may lead to enhanced early interventions to reverse
or halt their progression and improve clinical out-
comes. We have not suggested that we undertake
brain imaging in every patient harboring a vascular
risk factor (1).Joseph I. Friedman, MD*
Cheuk Y. Tang, PhD
Zahi A. Fayad, PhD
Valentin Fuster, MD
Jagat Narula, MD
*Department of Psychiatry
Department of Neuroscience
Icahn School of Medicine at Mount Sinai
1450 Madison Avenue, Ofﬁce 533
New York, New York 10029
E-mail: Joseph.friedman@mssm.edu
http://dx.doi.org/10.1016/j.jcmg.2014.11.014
R EF E RENCE S
1. Friedman JI, Tang CY, de Haas HJ, et al. Brain imaging changes associated
with risk factors for cardiovascular and cerebrovascular disease in asymp-
tomatic patients. J Am Coll Cardiol Img 2014;7:1039–53.
2. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle
management to reduce cardiovascular risk: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol 2014;63:2960–84.
